Empower your routine PCR testing with the flexibility to target just what you need and strategically streamline your workflow with industry-exclusive assay innovation only from Roche.
Providing gold-standard PCR technology with the cobas® 5800/6800/8800 Systems, Roche continues to innovate and invest to deliver personalized healthcare to your patients.
Critical viruses detected by the cobas® Respiratory flex1 assay will include:
Customize your assay offering to match testing algorithms for the Emergency Department, Physician Office, Hospital Lab, and Independent Labs.
Match patient need with the necessary pathogens for your testing population; up to 12 respiratory targets from a single sample.
Address seasonality changes to customize your test offering; design winter and summer respiratory panels.
Adapt to geographies to test what is clinically relevant in your region.
Upon clearance, this assay will further complement our cobas® x800 respiratory portfolio to address the needs of patients experiencing respiratory illness and aligns with our commitment to assist you in providing accurate and customizable respiratory testing for your patients.
Reference
Connect with us to stay informed on the submission progress of cobas® Respiratory flex.
Roche is the only manufacturer to offer the complete PCR Ecosystem† - providing high-quality respiratory testing solutions across the entire healthcare continuum. From consolidated IVD laboratory testing to solutions that complement syndromic panel testing and at the point of care.
† Based on third party market analysis. Data on file.
